Skip to main content

Table 4 Final EBV status for all 518 analyzable samples

From: Reliability of the Siemens Enzygnost and Novagnost Epstein–Barr Virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein–Barr Virus immunofluorescence assay

  Number Percent of population
Negative 39 7.5
Acute infection 15 2.9
Past infection 464 89.6